我要投票 香雪XPH在医疗器械行业中的票数:151
· 外 推 电 报 ·
2025-04-03 18:40:40 星期四

【香雪XPH是哪个国家的品牌?】

香雪XPH是什么牌子?「香雪XPH」是 广州市香雪制药股份有限公司 旗下著名品牌。该品牌发源于广东省广州市,由创始人王董在1986年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力香雪XPH品牌出海!通过在本页面挂载香雪XPH品牌的产品链接和联系邮箱,可以提高香雪XPH产品曝光!跨境电商爆单神器,目前只要100元/年哦~

广州市香雪制药股份有限公司,始于1986年,广东省名牌,药典标准制定者,大中药健康产业领先者,现代化高新技术医药企业


“十里梅花浑似雪,萝岗香雪映朝阳。”诗人郭沫若赋诗赞赏的羊城八景之一“萝岗香雪”, 正是香雪制药的发祥地。1986年萝岗制药厂成立,1997年改制为广州市香雪制药股份有限公司,于2010年在中国深圳证券交易所公开发行股票(IPO)挂牌上市(股票代码:300147)。秉承“厚生、臻善、维新”的经营理念,公司把发展中药和实现中药现代化作为长远发展战略,经多年发展,现已成为拥有自主知识产权、自主品牌、自主创新能力的中药现代化的领军企业和技术企业,形成中药资源开发、中药先进制造、现代物流配送、新药创制的完整产业链。香雪制药先后在广东、北京、山西、四川、重庆、安徽、云南和宁夏等地设立十八间公司并投资兴建大规模的GMP生产基地和GAP药材种植基地,形成了新型中药饮片、中成药、功能健康食品(饮料)、养生保健等产品群所组成的大中药健康产业,在中国创造就业职位一万余个。

数字化中药

香雪制药致力于中药现代化的研究和实践,在中药现代化的关键技术——中成药质量控制技术、现代制剂技术、中药给药途径创新等研究取得丰硕成果及突破。香雪制药建立了以“现代中药指纹图谱质量控制技术”为核心的现代中药集成创新系统,应用指纹图谱质控技术,通过计算机相似度分析系统使得成分复杂的中药质量得到有效控制;应用中药临床循证医学评价方法,通过大样品、多中心的大规模临床数据评价使中药疗效准确与经济。香雪制药引进全球先进的信息管理系统,使中药生产经营、销售服务过程实现全面信息资源管理,对企业资源、供应链、客户关系、节能环保、智能办公等方面完成高度集成,使中药企业管理与大数据时代接轨。


英文翻译:Guangzhou Xiangxue Pharmaceutical Co., Ltd. started in 1986. It is a famous brand in Guangdong Province, a standard maker of Pharmacopoeia, a leader in the health industry of traditional Chinese medicine, and a modern high-tech pharmaceutical enterprise Luogang Xiangxue, one of the eight sceneries in Yangcheng, is the birthplace of Xiangxue pharmaceutical. Luogang pharmaceutical factory was established in 1986, and was restructured into Guangzhou Xiangxue Pharmaceutical Co., Ltd. in 1997. It was listed on the Shenzhen Stock Exchange in 2010 (Stock Code: 300147). Adhering to the business philosophy of "health, perfection and renovation", the company takes the development of traditional Chinese medicine and the modernization of traditional Chinese medicine as its long-term development strategy. After years of development, the company has become a leading enterprise and technical enterprise with independent intellectual property rights, independent brand and independent innovation ability, forming the development of traditional Chinese medicine resources, advanced manufacturing of traditional Chinese medicine, modern logistics and distribution, and the creation of new drugs A complete industrial chain. Xiangxue pharmaceutical has successively set up 18 companies in Guangdong, Beijing, Shanxi, Sichuan, Chongqing, Anhui, Yunnan and Ningxia and invested in the construction of large-scale GMP production base and gap medicine planting base, forming a large traditional Chinese medicine health industry composed of new traditional Chinese medicine pieces, proprietary Chinese medicine, functional health food (beverage), health care and other product groups, creating jobs in China More than 10000. Xiangxue pharmaceutical is committed to the research and practice of the modernization of traditional Chinese medicine, and has made fruitful achievements and breakthroughs in the key technologies of the modernization of traditional Chinese medicine, such as the quality control technology of traditional Chinese medicine, the modern preparation technology, and the innovation of the way of administration of traditional Chinese Medicine. Xiangxue pharmaceutical has established a modern integrated innovation system of traditional Chinese medicine with "modern fingerprint quality control technology" as the core. By using fingerprint quality control technology and computer similarity analysis system, the quality of traditional Chinese medicine with complex components can be effectively controlled. By using the clinical evidence-based medicine evaluation method of traditional Chinese medicine, the quality of traditional Chinese medicine can be effectively controlled through large-scale clinical data evaluation of large samples and multi centers The therapeutic effect is accurate and economical. Xiangxue pharmaceutical introduced the world's advanced information management system to realize the comprehensive information resource management in the process of Chinese medicine production, operation and sales service, and highly integrated the enterprise resources, supply chain, customer relationship, energy conservation and environmental protection, intelligent office, etc., so as to make the Chinese medicine enterprise management in line with the big data era.

本文链接: https://www.waitui.com/brand/5a03ebbad.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

证监会:进一步完善全链条全生命周期的多层次市场服务体系,加力支持优质民营企业做强做优做大

36氪获悉,证监会召开深化资本市场投融资综合改革民营科技企业座谈会。吴清强调,民营经济是国民经济的重要组成部分,是推动科技创新的重要力量。大力支持民营经济发展,既是资本市场服务实体经济的内在要求,也是加快培育高质量上市公司和促进资本市场高质量发展的重要着力点。尊重市场规律,切实提升资本市场的包容性、适应性,持续增强规则的透明度、可预期性,进一步完善全链条全生命周期的多层次市场服务体系,加力支持优质民营企业做强做优做大。

41分钟前

吴清:民营科技企业作为民营经济和新质生产力领域的优秀代表,希望大家坚定信心,保持爱拼才会赢的精气神

证监会党委书记、主席吴清在北京召开专题座谈会,与集成电路、新能源汽车、智能制造、新材料、商业航天、网络经济等不同领域的民营科技企业代表深入交流。吴清强调,进一步完善全链条全生命周期的多层次市场服务体系,加力支持优质民营企业做强做优做大。民营科技企业作为民营经济和新质生产力领域的优秀代表,希望大家坚定信心,保持爱拼才会赢的精气神,以实际行动发挥好示范带头作用,积极利用资本市场转型升级、做优做强,更好回报投资者,为推动经济高质量发展和中国式现代化积极贡献力量。

41分钟前

广汽集团:3月汽车销量173929辆,同比下降3.01%

36氪获悉,广汽集团公告,3月汽车销量173929辆,同比下降3.01%。其中新能源汽车销量33362辆,同比下降0.72%。

41分钟前

盈富基金获南向资金净买入60.72亿港元

南向资金大幅净买入287.9亿港元,盈富基金、恒生中国企业、阿里巴巴-W分别获净买入60.72亿港元、48.33亿港元、34.87亿港元;申洲国际净卖出额居首,金额为0.12亿港元。(第一财经)

41分钟前

保诚委任新区域执行总裁

保诚(Prudential)4月3日宣布,将委任蔡强为区域执行总裁,负责马来西亚、印尼及越南和代理人销售事务。现任区域执行总裁(高增长市场、健康保险及代理人销售)索尔马兹‧阿尔丁(Solmaz Altin)决定返回欧洲。蔡强将加入集团行政委员会,并常驻香港及向执行总裁华康尧(Anil Wadhwani)汇报,委任将于四月七日生效。(界面)

41分钟前

本页详细列出关于仁和可立克的品牌信息,含品牌所属公司介绍,仁和可立克所处行业的品牌地位及优势。
咨询